Fundraising FoxPappas Capital — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Veraloxveralox.comNov 2024acquired by Cadrenal Therapeutics · Dec 2025 · $200K
Developing novel treatments based on the 12-LOX pathway for immuno-inflammatory diseases.
Co-investorsAlumni VenturesHatteras Venture PartnersPappas CapitalSanofi VenturesAlexandriaGenesys Capital+4 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.